Cidara Therapeutics Inc. Com New

13F holders, Q2 2025 (June 30)
2holders +1
2new positions
0sold out
$48.71avg. 13F price*

At the end of Q2 2025, 2 institutions reported holding Cidara Therapeutics Inc. Com New in their 13F filings, up 1 from Q2 2024. 2 opened new positions and 0 sold out. The largest holders were Jeppson Wealth Management, LLC ($300K) and Twin Peaks Wealth Advisors, LLC ($62).

Company
Cidara Therapeutics Inc. Com New
CUSIP
171757107
Latest filing quarter
Q4 2025

History

Number of 13F holders

01020304050 Q1 2024: 50Q1 2024Q2 2024: 1Q2 2024Q2 2025: 2Q2 2025Q3 2025: 5Q3 2025Q4 2025: 7Q4 2025

Total Exit/New Position Q2 2024 → Q2 2025

InstitutionsTotal Value
New Positions2$300K
Exits0$0

All 13F filers, Q2 2024 → Q2 2025: 6,156 shares bought, net +6,156 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 2 holders

Jeppson Wealth Management, LLC 0.10% New 6,155 $300K
Twin Peaks Wealth Advisors, LLC 0.00% New 1 $62

"% of holder's portfolio" is CIDARA THERAPEUTICS INC COM NEW's weight in each manager's 13F, not the share of Cidara Therapeutics Inc. Com New the manager owns.